Particle identification in a pharmaceutical solution
Your needs: identify the origin and nature of particles in your pharmaceutical solutions
What is a particle?
Behind the concept of particle or contamination, size is very often the key factor… A particle is a very small, sometimes residual, part of a chemical substance or material. Usually tiny, small particles may not be visible to the naked eye.
Why carry out particle identification?
In order to be marketed, new medicines undergo numerous clinical tests throughout their development, including particle identification. Once market authorization is approved, quality control checks on the medicine are carried out throughout its lifecycle and production to verify compliance.
The slightest particle or the slightest variation in the medicine can lead manufacturers to have to withdraw the pharmaceutical product from the market. That is why many protocols and analytical methods are developed to ensure product compliance according to the dedicated standards.
Have you identified an unknown particle in your pharmaceutical solution during your production process and would like to analyze it? Call on FILAB, a chemical analysis laboratory and pharmaceutical.
Our solutions: supporting medicine manufacturers in the identification of particles in their pharmaceutical solutions
Why choose FILAB?
The FILAB laboratory offers pharmaceutical manufacturers technical expertise and a state-of-the-art analytical platform to best meet their particle identification needs.
To provide precise and reliable answers to these issues, FILAB offers tailor-made support for the identification of your pharmaceutical solutions:
Our testing services and technical capabilities
FAQ
Particle identification in a pharmaceutical solution is the process by which scientists and healthcare professionals detect and characterize foreign particles present in liquid medicines. This helps ensure the safety, quality, and effectiveness of pharmaceutical products.
Particle identification in a pharmaceutical solution is of paramount importance for several reasons:
- Patient safety: foreign particles can cause allergic reactions, infections, or other adverse effects.
- Medicine efficacy: particles can alter the absorption or distribution of the medicine in the body, thereby compromising its effectiveness.
- Regulatory compliance: regulatory authorities require pharmaceutical manufacturers to meet product quality and purity standards.
Several methods are used to identify particles in a pharmaceutical solution, including:
- Visual inspection: healthcare professionals examine the solution with the naked eye or using a microscope to detect visible particles.
- Infrared spectroscopy: this technique analyzes the interactions between particles and infrared radiation to identify their composition.
- Scanning electron microscopy: this provides detailed visualization of particles and can be used to determine their structure and composition.
- Liquid chromatography: this method separates the components of the solution and makes it possible to identify particles based on their chemical or physical properties.
Several regulatory bodies, such as the FDA in the United States and the EMA in Europe, have established standards and guidelines for particle identification in pharmaceutical products. These standards specify tolerance thresholds for particles and justify approved analytical methods.
To ensure the reliability of particle identification results in a pharmaceutical solution, it is essential to follow good analytical practices, such as:
- Using validated and verified test methods.
- Regularly calibrating measuring instruments.
- Performing quality control checks and cross-checks with certified reference materials.
- Following strict sample handling procedures to avoid any contamination.
By entrusting your particle analysis to Filab, you ensure a reliable and professional result, with technical optimization recommendations provided if needed.
